OrbiMed Israel GP II, L.P.
CIK 1682090 · last filed 2022-01-27
OrbiMed Israel GP II, L.P. is a corporate insider who has filed 2 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing shows the insider sold $2.4M of ETNB on Jan 27, 2022. Across all open-market trades the lifetime net is +$32.3M, making them a net buyer over the disclosed history. The firm reports its address in New York, NY. 29 SEC filings were submitted jointly with OrbiMed Advisors Israel II Ltd.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
2
$32.26M
Filer Profile
54TH FLOOR
NEW YORK, NY 10022
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| 89bio, Inc. (ETNB) Delisted | 10%+ Owner | 1,829,436 | $14.84 | $27.15M | -$2.37M | 1 | 2022-01-27 |
| SteadyMed Ltd. (STDY) Delisted | 10%+ Owner | 2,123,098 | — | — | $34.63M | 1 | 2017-04-27 |
Recent Filings
2 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-01-27 | 89bio, Inc. (ETNB) Delisted | Sell (S) | −282,292 | -$2.37M | EDGAR |
| 2017-04-27 | SteadyMed Ltd. (STDY) Delisted | Buy (P) | +5,870,000 | $34.63M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.